Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
NCT ID: NCT01808872
Last Updated: 2014-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
569 participants
OBSERVATIONAL
2013-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187
VITROS Immunodiagnostic Products NT-proBNP II
NCT03548909
A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine
NCT01837849
Serial BNP Testing for Heart Failure Management
NCT00622531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart Failure
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is able to understand information given, and willing and able to voluntarily give their consent to participate in this study
* Subject has diagnosis of heart failure
Exclusion Criteria
* Subject has been diagnosed and/or treated for malignancy within past 6 months
* Subject has had cardiac surgery within the past 4 weeks
* Subject claim of pregnancy
* Subject's prior participation in this study
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radiometer Medical ApS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DC-043652
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.